June 4, 2026

LLIN Manufacturing Plant in India Malaria is by no means solved in India. The country has an unusually high burden of malaria in the South-East Asia Region of the WHO and vector control is the least expensive of the public health arsenal. Mosquito nets that are treated to kill or repel mosquitoes for up to three to five years are known as Long Lasting Insecticidal Nets (LLINs) and they are recommended by the WHO. For a long period of time, India has relied on imports for supplying institutional demand of the Ministry of Health and Family Welfare, state health departments, defence forces, and para-military forces. Now that that dependency is about to split open a realistic domestic manufacturing opportunity. The introduction of HIL (India) Limited in the LLIN manufacturing, where they have developed one product named as HILNET at their Rasayani plant in Maharashtra, is a positive sign for private participation in this sector. The initial capacity already in place is 10 million nets a year. Now, the Indian entrepreneurs have only one question to answer: will they be moving before the import window is closed? Why This Sector Is a Strong Startup Opportunity Demand signal is clear and institutionalized. The Ministry of Health and Family Welfare (MoHFW) is the buyer of LLINs under the National Vector Borne Disease Control Programme (NVDCP), and the demand for LLINs has been estimated to be at the rate of tens of millions of nets per year. There is also a contribution from the Central Armed Police Forces (CAPFs), defence establishments and NGO distribution chains. Historically all this procurement has been done through imports from countries such as Thailand, China, Sri Lanka etc which make India vulnerable to price volatility and supply disruptions. This has left the government with a proactive drive to develop locally manufactured options. In the Annual Report 2025-26 of Ministry of Chemicals and Fertilizers, Government of India,  Limited developed and commercialized LLINs with a motive to minimize dependence on imports and contribute to the Atmanirbhar Bharat programme. The report further states that the following agencies are being supplied: Ministry of Health and Family Welfare, state health departments, defence forces, CAPFs, PSUs and NGOs — which means that any private LLIN manufacturing company in India would be their direct target. Investment-wise, this is a sector that has proven institutional buyers, provable import substitution rationale and policy support. It is unusual to find that combination. For the majority of manufacturing startups, it’s an imperative that they build demand. LLIN entrepreneurs can enter into an already established, funded demand curve. However, there are real entry barriers that are not prohibitive. An Indian LLIN manufacturing plant which includes the polyethylene monofilament extrusion line, net-weaving machine, insecticide treatment line, and quality testing facilities generally requires an investment of Rs. in the project. 8 crores to Rs. The cost, depending on size and automation, is 25 crores. The licensing requirements are that it must be registered with the Central Insecticide Board and Registration Committee (CIB&RC) and meet the WHO standards (PES 60 denier standard). High density polyethylene (HDPE) granules, LLDPE granules and alpha-cypermethrin / deltamethrin active ingredients are all available domestically as raw materials. The government scheme support is available via PMEGP (small units up to Rs. 20 lakh project cost under manufacturing, CGTMSE collateral free facilities for MSMEs and potential PLI benefits to LLIN nets in specialty textile and technical textile categories. Related Article: India vs China Manufacturing: Best Business Opportunities, High Profit Sectors & Startup Ideas in India Business Selection Logic and Margin Structure There are two decisions involved in the profitability of LLIN manufacturing: product specification and buyer segmentation. WHO-prequalified LLINs cost more in institutional procurement, and have a higher level of investment in testing, documentation and compliance. Non-pre-qualified nets for domestic level buyers of MSMEs or government schemes of sub-national level are characterized by lower entry cost, but are subjected to margin pressure. A mid-scale LLIN manufacturing plant, capable of producing 2-3 million LLINs per annum, can have an EBITDA margin of 18-24% with institutional supply contracts. Polymer granules, which account for approximately 35-40 percent of cost of goods sold, and insecticide active ingredients, which account for approximately 12-15 percent, are the two most significant cost drivers, as is energy. The cost of labour is significantly lower in Tier-2 manufacturing hubs such as Nagpur, Nashik and Aurangabad compared to metros. Modular investment in extrusion lines is required to achieve scalability from a pilot unit of 500,000 nets per year to a medium size unit of 5 million nets. The capital equipment used is mostly conventional, adapted to technical requirements — not fancy. The learning curve will be manageable to technical textile promoters, agri- nets promoters, and shade nets promoters. Here, being aware of the danger is important. The regulatory risk is the most acute one: WHO prequalification is not a straightforward process, and CIB&RC registration requires time. The risk that comes from the government’s demand side is that the number of tenders or the volume of demand for a year may change. Raw material risk, particularly in the case of insecticide active ingredients, can be addressed, to a certain extent, by contract manufacturing agreements or in-house blending. However, those entrepreneurs, who establish direct relationships with the NHM procurement officers, instead of depending on the open tenders, get much better capacity utilisation.   LLIN Manufacturing: Project Opportunity Matrix Project Type Production Scale Target Buyer Capex Range Margin Outlook LLIN Net Weaving Unit (Pilot) 0.5–1 million nets/annum State health depts, NGOs Rs. 4–8 Cr 12–16% Integrated LLIN Plant (Mid-Scale) 2–5 million nets/annum MoHFW, CAPFs, Defence Rs. 10–20 Cr 18–24% WHO Prequalified Export Unit 5–10 million nets/annum Africa via WHO/UNICEF tenders Rs. 20–35 Cr 22–28% Net Finishing & Treatment Hub 2–3 million retreated nets MoHFW, state depts Rs. 3–6 Cr 14–18% Polymer Yarn Extrusion (Upstream) 500–1,000 MT yarn/annum LLIN manufacturers Rs. 6–12 Cr 16–20% Product and Project Opportunities Under the LLIN Sector 1. Integrated LLIN Manufacturing Plant (Full Value Chain) This is the opportunity